Wells Fargo’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349 | Sell |
39
-467
| -92% | -$4.18K | ﹤0.01% | 5948 |
|
|
2025
Q1 | $3.2K | Buy |
506
+11
| +2% | +$69 | ﹤0.01% | 5627 |
|
|
2024
Q4 | $5.11K | Buy |
495
+143
| +41% | +$1.48K | ﹤0.01% | 5556 |
|
|
2024
Q3 | $4.52K | Hold |
352
| – | – | ﹤0.01% | 5523 |
|
|
2024
Q2 | $4.88K | Buy |
352
+347
| +6,940% | +$4.81K | ﹤0.01% | 5494 |
|
|
2024
Q1 | $1.56K | Hold |
5
| – | – | ﹤0.01% | 5679 |
|
|
2023
Q4 | $1.29K | Buy |
5
+1
| +25% | +$259 | ﹤0.01% | 5727 |
|
|
2023
Q3 | $864 | Buy |
4
+2
| +100% | +$432 | ﹤0.01% | 5857 |
|
|
2023
Q2 | $489 | Hold |
2
| – | – | ﹤0.01% | 6185 |
|
|
2023
Q1 | $229 | Hold |
2
| – | – | ﹤0.01% | 6416 |
|
|
2022
Q4 | $355 | Hold |
2
| – | – | ﹤0.01% | 6151 |
|
|
2022
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 6055 |
|
|
2022
Q2 | $1K | Sell |
2
-9
| -82% | -$4.5K | ﹤0.01% | 6247 |
|
|
2022
Q1 | $2K | Hold |
11
| – | – | ﹤0.01% | 6325 |
|
|
2021
Q4 | $2K | Hold |
11
| – | – | ﹤0.01% | 6332 |
|
|
2021
Q3 | $5K | Buy |
11
+1
| +10% | +$455 | ﹤0.01% | 6044 |
|
|
2021
Q2 | $4K | Sell |
10
-32
| -76% | -$12.8K | ﹤0.01% | 6061 |
|
|
2021
Q1 | $24K | Sell |
42
-28
| -40% | -$16K | ﹤0.01% | 5738 |
|
|
2020
Q4 | $40K | Buy |
70
+48
| +218% | +$27.4K | ﹤0.01% | 5451 |
|
|
2020
Q3 | $12K | Sell |
22
-20
| -48% | -$10.9K | ﹤0.01% | 5550 |
|
|
2020
Q2 | $24K | Buy |
+42
| New | +$24K | ﹤0.01% | 5361 |
|